• ICON entered a multi-year collaboration with Anthropic to deploy Claude AI across the clinical trial lifecycle via its Orbis platform.
• Deal targets faster trial execution through AI-driven site selection, study planning, predictive operational monitoring, protocol design, agent deployment.
• Rollout includes Claude Code for developers, Claude for knowledge teams, Claude Science for scientific and clinical teams.
• Partnership aims to embed ICON trial intelligence into sponsor workflows, enabling secure access to ICON insights within Claude.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ICON plc published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.